Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigating the treatment of vascular risk with simvastatin in secondary progressive multiple sclerosis: analysis from the MS-STAT2 randomized controlled trial.

Brain communications·2026
Same author

Neurofilament Light Chain in Cerebrospinal Fluid and Blood Identifies Patients With Minimal and Overt Hepatic Encephalopathy.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Challenges and future directions for multiple sclerosis after the 2024 McDonald diagnostic criteria.

Nature medicine·2026
Same author

Application of serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) as biomarkers in the clinical management of multiple sclerosis (NeuroFilMS): a protocol for an observational cohort study.

BMJ open·2026
Same author

Quantifying cortical lesions in multiple sclerosis MRI datasets using multi-contrast post-processing and deep learning.

Communications medicine·2026
Same author

Assessing Progression Independent of Relapse Activity in Multiple Sclerosis Using a Patient-Reported Disability Measure and Self-Administered Neuroperformance Outcomes.

Annals of neurology·2026

Related Experiment Video

Updated: May 21, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Rethinking prognosis in multiple sclerosis: a multiaxial perspective.

Luca Prosperini1, Carla Tortorella1, Frederik Barkhof2,3

  • 1MS Centre, Department of Neurosciences, San Camillo-Forlanini Hospital, Rome, Italy.

Nature Reviews. Neurology
|May 19, 2026
PubMed
Summary

This study proposes a new multiaxial model for multiple sclerosis (MS) prognosis, integrating damage, injury location, and compensation capacity. This framework aims to improve individualized risk prediction beyond current disease burden assessments.

More Related Videos

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
05:44

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

Published on: October 13, 2023

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Related Experiment Videos

Last Updated: May 21, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
05:44

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

Published on: October 13, 2023

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Area of Science:

  • Neurology
  • Biomarker Research
  • Medical Imaging

Background:

  • Multiple sclerosis (MS) prognosis remains uncertain despite therapeutic advances.
  • Current prognostic approaches primarily focus on disease burden, neglecting compensatory mechanisms.
  • A unified framework for integrating diverse prognostic factors in MS is lacking.

Purpose of the Study:

  • To propose a multiaxial conceptual model for multiple sclerosis prognosis.
  • To integrate diverse prognostic factors including damage, injury topography, and compensation.
  • To provide a roadmap for future research in MS prognostic modeling.

Main Methods:

  • Review of current research on MS prognosis by the MAGNIMS consortium.
  • Development of a three-axis conceptual model: damage burden, injury topography, and compensation capacity.
  • Evaluation of existing tools (MRI, biofluid markers, evoked potentials, OCT, passive monitoring) for assessing prognostic axes.

Main Results:

  • A novel multiaxial conceptual model for MS prognosis is proposed.
  • The model integrates overall damage, lesion location, and compensatory mechanisms.
  • Existing tools and future directions for each axis were assessed.

Conclusions:

  • The proposed framework offers an integrated approach to individualized risk prediction in MS.
  • This conceptual roadmap aims to guide future research and refine prognostic models.
  • The model is intended as a guide for research, not a prescriptive clinical guideline.